FDA Inspection
Grifols Biologicals LLCGrifols Biologicals LLC – FDA Inspection, May 3, 2024
Record Details
This FDA Inspection record concerns Grifols Biologicals LLC, with an inspection on May 3, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 989e2003-63ee-4724-a9cb-054ab6816dd1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1229139
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.198(a)Complaint Handling Procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Grifols Biologicals LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 17, 2026 | Not classified | Los Angeles District Office | Blood and Blood Products |
| September 12, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 31, 2019 | Not classified | Los Angeles District Office | |
| August 24, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 20, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Biologicals LLC
- FDA Inspection 1336990 - 2026-09-17
- FDA Inspection 1105923 - 2019-09-12
- FDA Inspection 1088286 - 2019-01-31
- FDA Inspection 1027351 - 2017-08-24
- FDA Inspection 944819 - 2015-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.